SLN: Silence Therapeutics plc – Depositary Receipt (Common Stock) Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 17.05
Book Value / Share 0.37
Price / Book n/a
NCAV ($M) 4.25
NCAV / Share 0.09
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -2.50
Return on Assets (ROA) -0.40
Return on Equity (ROE) -1.96

Liquidity (mrq)
Quick Ratio 4.56
Current Ratio 4.56

Balance Sheet (mrq) ($M)
Current Assets 81.02
Assets 93.82
Liabilities 76.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 25.38
Operating Income -49.60
Net Income -43.27

Cash Flow Statement (mra) ($M)
Cash From Operations -39.35
Cash from Investing 16.43
Cash from Financing 25.16

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G/A Goldman Sachs Group Inc 2.20
02-09 13G/A Artal International S.C.A. 7.80

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 16,063 113,862 14.11
2024-03-27 29,835 40,104 74.39
2024-03-26 26,141 171,024 15.28
2024-03-25 23,573 142,523 16.54

(click for more detail)

Similar Companies
ACAB – Atlantic Coastal Acquisition Corp. II ACET – Adicet Bio, Inc.
ACIU – AC Immune SA ACRV – Acrivon Therapeutics, Inc.
ADMA – ADMA Biologics, Inc.


Financial data and stock pages provided by
Fintel.io